AGICC
Providing expertise and innovative solutions for the rapid design, implementation, management and completion of complex GI cancer trials.

The Aptium Oncology GI Cancer Consortium (AGICC) is an innovative research model that brings together a world class team of institutions and investigators to design and rapidly complete clinical trials in gastrointestinal (GI) cancers.

“I can’t emphasize enough the value that will be added by having AGICC involved in a GI trial. What you get are the highest quality institutions working together to complete a study faster and with the best possible data.”
— Jordan Berlin, MD, Vanderbilt University